Conversion to neoral provides effective rescue therapy for liver and kidney transplant patients intolerant of Prograf.
Abouljoud
M
M
Henry Ford Hospital, Detroit, Michigan, USA.
Kumar
M S
MS
Brayman
K
K
Emre
S
S
Bynon
S J
SJ
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D018592:Cross-Over Studies; D016572:Cyclosporine / Q000627:therapeutic use*; D005260:Female; D006084:Graft Rejection / Q000188:drug therapy*; D006801:Humans; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D016031:Liver Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D016879:Salvage Therapy; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use*
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus